1-3 of 3
Hideo Hyodo, MD
Close
Sort by
Journal Articles

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Mitsune Tanimoto, MD PhD, Koichi Miyamura, Toshihiro Miyamoto, MD PhD, Kazuhito Yamamoto, Masafumi Taniwaki, Shinya Kimura, MD, Kazuma Ohyashiki, Tatsuya Kawaguchi, MD PhD, Itaru Matsumura, Tomoko Hata, MD PhD, Hisashi Tsurumi, MD PhD, Shigeki Saito, MD PhD, Masayuki Hino, MD PhD, Seiji Tadokoro, Kuniaki Meguro, MD PhD, Hideo Hyodo, MD, Masahide Yamamoto, MD PhD, Kohmei Kubo, MD PhD, Junichi Tsukada, MD, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada
Journal: Blood
Blood (2014) 124 (21): 1815.
https://doi.org/10.1182/blood.V124.21.1815.1815
Published: 2014
Journal Articles

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Koichi Miyamura, MD, PhD, Toshihiro Miyamoto, MD, Mineo Kurokawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Masafumi Taniwaki, MD, PhD, Shinya Kimura, MD, PhD, Kazuma Ohyashiki, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Itaru Matsumura, MD, PhD, Tomoko Hata, MD, PhD, Hisashi Tsurumi, MD, PhD, Shigeki Saito, MD, PhD, Masayuki Hino, MD, PhD, Seiji Tadokoro, Kuniaki Meguro, M.D., Ph.D., Hideo Hyodo, MD, Masahide Yamamoto, MD, Kohmei Kubo, MD, Junichi Tsukada, Midori Kondo, Taro Amagasaki, PhD, Eiji Kawahara, PhD, Masamitsu Yanada
Journal: Blood
Blood (2013) 122 (21): 2729.
https://doi.org/10.1182/blood.V122.21.2729.2729
Published: 2013
Journal Articles

Expansion of CD8 + /perforin + T-Cell Subset in Patients Predicts Response to Cyclosporin A Therapy in Patients with Erythroid Hypoplasia/Aplasia

Hideaki Nitta, MD, Yuka Harada, MD, Hideo Hyodo, MD, Akiro Kimura, MD, Hironori Harada, MD
Journal: Blood
Blood (2011) 118 (21): 1337.
https://doi.org/10.1182/blood.V118.21.1337.1337
Published: 2011